Clara Park, Breast Cancer Surgeon at Brigham and Women’s Hospital, shared a post on X:
“Important study on SLNB for pts with palp ax adenopathy: N= 78 upfront surgery with cT1-2cN1 HR+HER2− breast cancer, <=3 abnormal lymph nodes on Ax US, 69% pN+ and were able to avoid ALND, no isolated axillary recurrences median f/u 25 months (n = 68).”
Title: Sentinel Lymph Node Biopsy for Patients With cN1 HR+/HER2− Breast Cancer and Palpable Adenopathy
Authors: Anita Mamtani, Melissa Pilewskie, Niamey Wilson, Heiwon Chung Whang, Andrea V. Barrio, Leah Bassin, Deborah Capko, Daniel X. Choi, Hiram S. Cody III, Stephanie Downs-Canner, Mahmoud El-Tamer, Mary L. Gemignani, Alexandra S. Heerdt, Laurie Kirstein, Minna K. Lee, Victoria L. Mango, Giacomo Montagna, Tracy-Ann Moo, Jacqueline Oxenberg, George Plitas, Michael Sabel, Virgilio Sacchini, Lisa Sclafani, Varadan Sevilimedu, Audree B. Tadros, Kimberly J. Van Zee, Monica Morrow.
Other articles featuring Clara Park on OncoDaily.